Literature DB >> 9817892

Sequence variation within three important cytomegalovirus gene regions in isolates from four different patient populations.

B Zweygberg Wirgart1, M Brytting, A Linde, B Wahren, L Grillner.   

Abstract

We determined the nucleotide (nt) and amino acid (aa) heterogeneities of three distinct regions of the human cytomegalovirus (CMV) genome for 46 low-passage CMV isolates from four different patient populations (congenitally infected infants, children attending day-care centers, renal transplant recipients, and human immunodeficiency virus-infected individuals) and for two laboratory strains (CMV Ad169 and Towne). The gene regions for the major immediate-early (MIE) exon 4 gene (nt positions 1702 to 1982, aa positions 152 to 244), the DNA polymerase gene (nt positions 2797 to 3046, aa positions 713 to 795), and the glycoprotein B (gB) gene (nt positions 1698 to 1884, aa positions 567 to 628) were sequenced. The sequence information was used to design sets of nested PCR primers directed against the most highly conserved regions identified. MIE was the most variable gene region compared to the variability of the DNA polymerase and gB gene regions. Comparison of the sequences of all 46 isolates with that of Ad169 revealed nt and aa sequence homologies of 87.9 and 87.2%, respectively, within the MIE gene compared to 92.8 and 100% homologies, respectively, within the DNA polymerase gene and 93 and 95.2% homologies, respectively, within the gB gene. Within the MIE gene, compared to the Ad169 nt sequence the homology at the nt level among isolates obtained from children attending day-care centers was high (96.4%), while it was lower (90%) among isolates obtained from the other three patient populations. Preliminary results of a nested PCR with oligonucleotide primers selected from the DNA polymerase gene region with a low level of nt sequence variation indicates that primers selected from this region might be more powerful for use in PCR than primers selected from the MIE gene region.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817892      PMCID: PMC105259     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.

Authors:  B Z Wirgart; K Claesson; B M Eriksson; M Brundin; G Tufveson; T Tötterman; L Grillner
Journal:  Clin Diagn Virol       Date:  1996-11

Review 2.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition.

Authors:  J S Gibbs; H C Chiou; K F Bastow; Y C Cheng; D M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  The structure of the major immediate early gene of human cytomegalovirus strain AD169.

Authors:  A Akrigg; G W Wilkinson; J D Oram
Journal:  Virus Res       Date:  1985-03       Impact factor: 3.303

5.  General colorimetric method for DNA diagnostics allowing direct solid-phase genomic sequencing of the positive samples.

Authors:  J Wahlberg; J Lundeberg; T Hultman; M Uhlén
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage.

Authors:  R R Spaete; R M Thayer; W S Probert; F R Masiarz; S H Chamberlain; L Rasmussen; T C Merigan; C Pachl
Journal:  Virology       Date:  1988-11       Impact factor: 3.616

7.  A prospective molecular epidemiological study of cytomegalovirus infections in two day care centers in Sweden: no evidence for horizontal transmission within the centers.

Authors:  L Grillner; K Strangert
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

8.  Sequence and transcription analysis of the human cytomegalovirus DNA polymerase gene.

Authors:  T Kouzarides; A T Bankier; S C Satchwell; K Weston; P Tomlinson; B G Barrell
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

9.  Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.

Authors:  M P Cranage; T Kouzarides; A T Bankier; S Satchwell; K Weston; P Tomlinson; B Barrell; H Hart; S E Bell; A C Minson
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

10.  Human DNA polymerase alpha gene expression is cell proliferation dependent and its primary structure is similar to both prokaryotic and eukaryotic replicative DNA polymerases.

Authors:  S W Wong; A F Wahl; P M Yuan; N Arai; B E Pearson; K Arai; D Korn; M W Hunkapiller; T S Wang
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  22 in total

1.  Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination.

Authors:  Winsome Barrett Muir; Richard Nichols; Judith Breuer
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Coding potential of laboratory and clinical strains of human cytomegalovirus.

Authors:  Eain Murphy; Dong Yu; Jane Grimwood; Jeremy Schmutz; Mark Dickson; Michael A Jarvis; Gabriele Hahn; Jay A Nelson; Richard M Myers; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

3.  Cross-reactivity of HLA-B*1801-restricted T-lymphocyte clones with target cells expressing variants of the human cytomegalovirus 72kDa-IE1 protein.

Authors:  Virginie Prod'homme; Christelle Retière; Ralitza Valtcheva; Marc Bonneville; Marie-Martine Hallet
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

4.  Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation.

Authors:  Xiaoli L Pang; Linda Chui; Jayne Fenton; Barbara LeBlanc; Jutta K Preiksaitis
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

5.  The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates.

Authors:  Lucy Rasmussen; Aimee Geissler; Catherine Cowan; Amanda Chase; Mark Winters
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Comparison of a duplex quantitative real-time PCR assay and the COBAS Amplicor CMV Monitor test for detection of cytomegalovirus.

Authors:  Björn Herrmann; Viviana Cavaglia Larsson; Carl-Johan Rubin; Fredrik Sund; Britt-Marie Eriksson; Johan Arvidson; Zhibing Yun; Kåre Bondeson; Jonas Blomberg
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

7.  Real-time PCR diagnostics failure caused by nucleotide variability within exon 4 of the human cytomegalovirus major immediate-early gene.

Authors:  Martina Lengerova; Zdenek Racil; Pavlina Volfova; Jana Lochmanova; Jitka Berkovcova; Dana Dvorakova; Jiri Vorlicek; Jiri Mayer
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

8.  Sequence diversity in the glycoprotein B gene complicates real-time PCR assays for detection and quantification of cytomegalovirus.

Authors:  Melinda B Nye; Adam R Leman; Michelle E Meyer; Marilyn A Menegus; Paul G Rothberg
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

9.  Detailed polymorphism study on cytomegalovirus DNA polymerase gene to reveal the most suitable genomic targets for quantitative Real-time PCR.

Authors:  Onur Bilenoğlu; Mustafa Altındiş; Ersoy Öz; Yeliz Yücel-Öz; Öykü İrigül-Sönmez; Can Bora Ünal
Journal:  Bosn J Basic Med Sci       Date:  2015-06-23       Impact factor: 3.363

10.  Human cytomegalovirus UL145 gene is highly conserved among clinical strains.

Authors:  Zhengrong Sun; Ying Lu; Qiang Ruan; Yaohua Ji; Rong He; Ying Qi; Yanping Ma; Yujing Huang
Journal:  J Biosci       Date:  2007-09       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.